Therapeutic advances in dystonia

Alberto Albanese, Luigi Michele Antonio Romito, Luigi M. Romito, Daniela Calandrella

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

16 Citazioni (Scopus)


Knowledge on dystonia has greatly improved recently, because of a renewed effort in understanding its cause, pathophysiology, and clinical characterization. Different drug classes traditionally have been used for the symptomatic treatment of dystonia, more recently surpassed by the introduction of botulinum neurotoxins and deep brain stimulation. No curative or disease-modifying treatments are available. Recent knowledge regarding the pathophysiology of inherited dystonias is highlighting new potential treatment strategies. We review therapeutic advances in dystonia that have been published over the last 3 years, particularly regarding oral medications, local injections of botulinum neurotoxins, deep brain stimulation, and transcranial or epidural brain stimulations. We discuss evidence of efficacy, highlight recent advances, and focus on key areas under development.
Lingua originaleEnglish
pagine (da-a)1547-1556
Numero di pagine10
RivistaMovement Disorders
Stato di pubblicazionePubblicato - 2015


  • botutinum toxins
  • deep brain stimulation
  • dystonia
  • medication
  • surgery
  • treatment


Entra nei temi di ricerca di 'Therapeutic advances in dystonia'. Insieme formano una fingerprint unica.

Cita questo